Discontinued — last reported Q3 '23

Business Segments · Operating profit

Contract-Manufactured Products — Operating profit

West Pharmaceutical Services Contract-Manufactured Products — Operating profit increased by 40.9% to $21.00M in Q3 2023 compared to the prior quarter. Year-over-year, this metric grew by 42.9%, from $14.70M to $21.00M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ3 2023
Rolls up toOperating Income

How to read this metric

An increase indicates improved margins or operational efficiency, while a decrease suggests rising costs or pricing pressure in the contract manufacturing market.

Detailed definition

This metric measures the profitability of the Contract-Manufactured Products segment by subtracting operating expenses,...

Peer comparison

Standard segment-level profitability metric used across all public companies to evaluate business unit performance.

Metric ID: wst_segment_contract_manufactured_products_operating_profit

Historical Data

6 periods
 Q2 '21Q3 '21Q2 '22Q3 '22Q2 '23Q3 '23
Value$18.70M$16.80M$14.20M$14.70M$14.90M$21.00M
QoQ Change-10.2%-15.5%+3.5%+1.4%+40.9%
YoY Change-24.1%-12.5%+4.9%+42.9%
Range$14.20M$21.00M
CAGR+9.7%
Avg YoY Growth+2.8%
Median YoY Growth-3.8%
Current Streak3 quarters growth

Frequently Asked Questions

What is West Pharmaceutical Services's contract-manufactured products — operating profit?
West Pharmaceutical Services (WST) reported contract-manufactured products — operating profit of $21.00M in Q3 2023.
How has West Pharmaceutical Services's contract-manufactured products — operating profit changed year-over-year?
West Pharmaceutical Services's contract-manufactured products — operating profit increased by 42.9% year-over-year, from $14.70M to $21.00M.
What does contract-manufactured products — operating profit mean?
The profit generated by the contract manufacturing business after accounting for direct and indirect operating costs.